All News

2070 articles, sorted by publication time.

biology · global

Behind TREGZI’s Approval: Blood Cancer Transplantation Is No Longer Just About Replacing Bone Marrow, but Also Precisely Arranging Immune Order

The FDA has approved Orca Bio’s TREGZI for some adult patients with hematologic malignancies, moving allogeneic hematopoietic stem cell transplantation into a more refined design of cellular composition; it brings clinical signals of reduced chronic graft-versus-host disease, while also putting manufacturing, accessibility, and long-term safety on the same test paper.